Alivus Life Sciences Ltd.
ALIVUS Share PricePharmaceuticals & Drugs
₹920.55
-2.5 (-0.3%)
As on September 8, 2025
Exchange Scrips: BSE543322NSEALIVUSISININE03Q201024
Market Cap ₹ 11,323 Cr
P/E Ratio 23.23
Dividend Yield 0.27 %
Performance
Market performance
Open923.95
High932.15
Volumes51,260
Prev920.55
Low918
As on2025-09-08
Historical performance
1 Year High1,335.1
3 Year High1,335.1
5 Year High1,335.1
1 Year Low850
3 Year Low370
5 Year Low370
Fundamentals
Company Valuation
Market Cap (₹Cr)
11,323
Face Value (₹)
2
P/E Ratio
23.23
Dividend Yield
0.27 %
Investment Returns
1 Year
-20%
3 Years
110.4%
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 928.95 | Bearish |
| 10-DMA | 938.62 | Bearish |
| 20-DMA | 947.02 | Bearish |
| 50-DMA | 991.3 | Bearish |
| 100-DMA | 1,025.29 | Bearish |
| 200-DMA | 1,040.32 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 1 | 1 | 1 | 1 | 3 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 1 | 1 | 1 | 1 | 3 |
| Public Investors | 138499 | 141976 | 146839 | 143959 | 149393 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 23.23.
- 3Y Stock Price CAGR of the stock is 28.3.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹7172 Million.
- The company generated revenue of ₹23869 Million in the previous financial year.
Alivus Life Sciences Ltd.
920.55-2.5 (-0.3%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 763973.6
No. of Shares: 830 (Approx)
Performance:-23.6%
P/L: ₹-236026.4
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent